|
1
|
Correa MV, Nolly MB, Caldiz CI, de
Cingolani GE, Cingolani HE and Ennis IL: Endogenous endothelin 1
mediates angiotensin II-induced hypertrophy in electrically paced
cardiac myocytes through EGFR transactivation, reactive oxygen
species and NHE-1. Pflugers Arch. 466:1819–1830. 2014.PubMed/NCBI
|
|
2
|
de Jonge HW, Dekkers DH, Houtsmuller AB,
Sharma HS and Lamers JM: Differential signaling and hypertrophic
responses in cyclically stretched vs endothelin-1 stimulated
neonatal rat cardiomyocytes. Cell Biochem Biophys. 47:21–32. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin YJ, Kwok CF, Juan CC, Hsu YP, Shih KC,
Chen CC and Ho LT: Angiotensin II enhances endothelin-1-induced
vasoconstriction through upregulating endothelin type A receptor.
Biochem Biophys Res Commun. 451:263–269. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wolf AM, Wolf D, Avila MA, Moschen AR,
Berasain C, Enrich B, Rumpold H and Tilg H: Up-regulation of the
anti-inflammatory adipokine adiponectin in acute liver failure in
mice. J Hepatol. 44:537–543. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Piñeiro R, Iglesias MJ, Gallego R, Raghay
K, Eiras S, Rubio J, Diéguez C, Gualillo O, González-Juanatey JR
and Lago F: Adiponectin is synthesized and secreted by human and
murine cardiomyocytes. FEBS Lett. 579:5163–5169. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kistorp C, Faber J, Galatius S, Gustafsson
F, Frystyk J, Flyvbjerg A and Hildebrandt P: Plasma adiponectin,
body mass index, and mortality in patients with chronic heart
failure. Circulation. 112:1756–1762. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
George J, Patal S, Wexler D, Sharabi Y,
Peleg E, Kamari Y, Grossman E, Sheps D, Keren G and Roth A:
Circulating adiponectin levels predict outcome in patients with
severe congestive heart failure. Heart. 92:1420–1424. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wannamethee SG, Whincup PH, Lennon L and
Sattar N: Circulating adiponectin levels and mortality in elderly
men with and without cardiovascular disease and heart failure. Arch
Intern Med. 167:1510–1517. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Takano H, Obata JE, Kodama Y, Kitta Y,
Nakamura T, Mende A, Kawabata K, Saito Y, Fujioka D, Kobayashi T,
et al: Adiponectin is released from the heart in patients with
heart failure. Int J Cardiol. 132:221–226. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo B, Li Y, Han R, Zhou H and Wang M:
Angiotensin II upregulation of cardiomyocyte adiponectin production
is nitric oxide/cyclic GMP dependent. Am J Med Sci. 341:350–355.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Juan CC, Chuang TY, Chang CL, Huang SW and
Ho LT: Endothelin-1 regulates adiponectin gene expression and
secretion in 3T3-L1 adipocytes via distinct signaling pathways.
Endocrinology. 148:1835–1842. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bedi D, Clarke KJ, Dennis JC, Zhong Q,
Brunson BL, Morrison EE and Judd RL: Endothelin-1 inhibits
adiponectin secretion through a phosphatidylinositol
4,5-bisphosphate/actin-dependent mechanism. Biochem Biophys Res
Commun. 345:332–339. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yin WH, Chen YH, Wei J, Jen HL, Huang WP,
Young MS, Chen DC and Liu PL: Associations between endothelin-1 and
adiponectin in chronic heart failure. Cardiology. 118:207–216.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Skurk C, Wittchen F, Suckau L, Witt H,
Noutsias M, Fechner H, Schultheiss HP and Poller W: Description of
a local cardiac adiponectin system and its deregulation in dilated
cardiomyopathy. Eur Heart J. 29:1168–1180. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Lau WB, Gao E, Tao L, Yuan Y, Li
R, Wang X, Koch WJ and Ma XL: Cardiomyocyte-derived adiponectin is
biologically active in protecting against myocardial
ischemia-reperfusion injury. Am J Physiol Endocrinol Metab.
298:E663–E670. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kanno K, Hirata Y, Tsujino M, Imai T,
Shichiri M, Ito H and Marumo F: Up-regulation of ETB receptor
subtype mRNA by angiotensin II in rat cardiomyocytes. Biochem
Biophys Res Commun. 194:1282–1287. 1993. View Article : Google Scholar : PubMed/NCBI
|
